About Science & Research at FDA
An overview of science and research projects across the various components of FDA.
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
Guidances, Information Sheets, Notices and more.
Learn MoreThe Office of the Chief Scientist provides strategic leadership, coordination, and expertise, supporting scientific excellence, innovation and capacity to achieve FDA's public health mission.
The National Center for Toxicological Research conducts scientific research to generate data for FDA decision making, and develops and supports innovative tools and approaches that FDA uses to protect and promote public health.
The Oncology Center of Excellence will help expedite the development of oncology and hematology medical products and support an integrated approach in the clinical evaluation of drugs, biologics, and devices for the treatment of cancer.
FDA staff are involved in many activities intended to build regulatory science knowledge, facilitate collaborations and partnerships with stakeholders, and establish a flexible, product-focused, science-based approach to regulation of products that involve nanomaterials or applications of nanotechnology.
The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and court testimony.
FDA's Advancing Regulatory Science Initiative builds on the achievements of existing Agency programs, like the Critical Path Initiative's groundbreaking efforts to transform the way medical products are developed, evaluated, and manufactured.